5,083 Shares in Danaher Corporation $DHR Purchased by Doliver Advisors LP

Key Points

• Doliver Advisors LP acquired 5,083 Danaher shares worth approximately $1.126 million, while institutional investors and hedge funds collectively own 79.05% of the company.
• Danaher reported quarterly EPS of $1.94, beating estimates of $1.85, on revenue of $6.26 billion, up 5.5% year over year. Shares recently traded at $211.47, below the $232.50 average analyst price target.
• The company declared a quarterly dividend of $0.40 per share, equivalent to an annualized $1.60 payout and a 0.8% yield; analysts maintain a consensus “Moderate Buy” rating.

Doliver Advisors LP purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 5,083 shares of the conglomerate's stock, valued at approximately $1,126,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in Danaher in the 2nd quarter valued at $10,492,520,000. State Street Corp raised its holdings in Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate's stock worth $6,345,529,000 after acquiring an additional 472,608 shares in the last quarter. Capital International Investors boosted its position in Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate's stock valued at $4,177,386,000 after purchasing an additional 1,487,768 shares during the last quarter. Wellington Management Group LLP grew its stake in Danaher by 10.4% in the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate's stock valued at $3,108,031,000 after purchasing an additional 1,542,310 shares in the last quarter. Finally, Jupiter Topco LLC bought a new stake in shares of Danaher during the 2nd quarter worth approximately $1,456,317,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of NYSE DHR traded down $10.08 during trading hours on Thursday, reaching $211.47. 5,302,533 shares of the stock were exchanged, compared to its average volume of 4,477,097. The firm has a market capitalization of $148.66 billion, a price-to-earnings ratio of 37.56, a P/E/G ratio of 2.82 and a beta of 0.78. The stock's fifty day simple moving average is $208.38 and its 200 day simple moving average is $193.37. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the previous year, the company posted $0.77 EPS. The firm's quarterly revenue was up 5.5% on a year-over-year basis. Sell-side analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher's payout ratio is presently 28.42%.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Wells Fargo & Company decreased their target price on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 22nd. Guggenheim upped their target price on shares of Danaher from $200.00 to $250.00 and gave the company a "buy" rating in a report on Thursday. Weiss Ratings upgraded shares of Danaher from a "hold (c-)" rating to a "hold (c)" rating in a research note on Wednesday, September 16th. Royal Bank Of Canada boosted their price target on Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 22nd. Finally, UBS Group assumed coverage on Danaher in a research report on Wednesday, September 9th. They issued a "buy" rating and a $250.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, Danaher has an average rating of "Moderate Buy" and an average target price of $232.50.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.